New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2013
11:42 EDTAMAGAMAG sees FY13 revenue $73M- $77M, consensus $79.12M
AMAG sees Feraheme U.S. net product revenues of between $63M-$67M, driven by a combination of price and double-digit volume growth; Royalties and product sales related to ex-U.S. sales of Feraheme/Rienso and recognition of milestones of approximately $10M.
News For AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
20:03 EDTAMAGAMAG Pharmaceuticals 3.15M share Secondary priced at $63.75
Jefferies and Barclays acted as joint book running managers for the offering.
08:29 EDTAMAGAMAG says 'additional insight' gained into FTC investigation
Subscribe for More Information
08:26 EDTAMAGAMAG capital raise removes overhang, says Leerink
Subscribe for More Information
July 29, 2015
17:15 EDTAMAGAMAG Pharmaceuticals announces proposed offering of $200M of common stock
Subscribe for More Information
July 23, 2015
09:13 EDTAMAGOn The Fly: Pre-market Movers
Subscribe for More Information
07:25 EDTAMAGAMAG affirms FY15 revenue view $395M-$430M, consensus $465.45M
Raises FY15 adjusted EBITDA guidance view to $210M-$225M from $200M-$220M.
07:23 EDTAMAGAMAG reports Q2 adjusted EPS $1.12, one estimate $1.13
Subscribe for More Information
July 22, 2015
16:10 EDTAMAGAMAG acquires option for rights to Velo Bio's digoxin immune fab
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use